Trial Profile
The safety and efficacy of a ritonavir-enhanced Agenerase regimen as salvage therapy in HIV-infected individuals
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2005
Price :
$35
*
At a glance
- Drugs Amprenavir (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 20 Oct 2005 New trial record.